Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Mean body weight change of 14.9% at week 68 (STEP 1)
10.1002/ptr.6957 83 MoukhamH.LambiaseA.BaroneG
Effective January 1, 2026, Medi-Cal Rx is excluding coverage for GLP-1 medications prescribed for weight loss: [12] Wegovy, Zepbound, Saxenda: Completely removed from the Contract Drugs List for weight loss Ozempic, Mounjaro, Rybelsus: Restricted to Type 2 diabetes onlyweight loss claims will auto-deny Existing prior authorizations end December 31, 2025 Exceptions: Members under age 21 may still qualify via EPSDT Non-weight-loss indications (Zepbound for OSA, Wegovy for cardiovascular) may still get PA approval This does NOT affect Kaiser commercial or employer-sponsored plansonly Medi-Cal members
Stanley, and L
Nakamura, K., Yamamoto, H., Morishita, K., et al
